Lupin wins USFDA okay for HIV-1 drug Raltegravir Ruchika Sharma9 May 2025 10:15 AM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (USFDA) has approved the Company's...
Lupin unveils partial onset seizures drug Eslicarbazepine Acetate in US Ruchika Sharma8 May 2025 12:01 PM IST Mumbai: Global pharma major Lupin Limited has announced that the company has launched Eslicarbazepine Acetate Tablets, 200 mg, 400 mg, 600...
Revise study protocol: CDSCO Panels tells Lupin on Ranibizumab Solution for Injection 10 mg/mL Dr. Divya Colin30 April 2025 6:00 PM ISTNew Delhi: Responding to the drug major Lupin's proposal to conduct phase IV clinical trial of the ophthalmic drug Ranibizumab Solution for Injection...
Novo Nordisk Withdrawal to Reshape Insulin Market; Lupin's Huminsulin to Gain Spotlight Farhat Nasim24 April 2025 6:29 PM ISTMumbai: Amidst the ongoing news of conventional insulin market disruption and growing concern over potential shortages triggered by Novo...
Lupin gets green light from USFDA for kidney drug Tolvaptan Ruchika Sharma24 April 2025 11:52 AM ISTMumbai: Global pharma major, Lupin Limited, has received approval from the United States Food and Drug Administration (U.S. FDA) for...
Lupin recalls over 2000 bottles of antidepressant medication in US Ruchika Sharma23 April 2025 3:09 PM ISTUS: Lupin Pharmaceuticals Inc, a US-based subsidiary of Mumbai-headquartered Lupin is recalling over 2000 bottles of an antidepressant...
Lupin Diagnostics receives NABL accreditation for all Greenfield Labs Ruchika Sharma23 April 2025 11:15 AM ISTMumbai: Lupin Diagnostics Limited, a wholly owned subsidiary of global pharma major Lupin Limited, has received 100 percent National...
USFDA issues EIR for Lupin Nagpur Injectable facility Ruchika Sharma17 April 2025 3:00 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food...
BRESER Study Demonstrates Real-World Efficacy and Safety of Lupin's Ranibizumab Biosimilar (Ranieyes) Deeksha Bhandari11 April 2025 11:24 AM ISTRanieyes is the Ranibizumab Biosimilar which is an Indian Ranibizumab Biosimilar manufactured by Lupin Ltd & approved in India for various...
Right Turn Show- Exploring Dapagliflozin Beyond Glycemic Benefits Deeksha Bhandari8 April 2025 12:34 PM ISTIn the last episode, we explored the role of Dapagliflozin in specialty care settings. Moving forward, this episode delves into Dapagliflozin Beyond...
Lupin UK arm acquires Renascience Pharma for over Rs 138 crore Ruchika Sharma3 April 2025 1:30 PM ISTMumbai: Lupin Healthcare (UK) Limited, the wholly owned subsidiary of global pharma major Lupin Limited, has announced the acquisition of ...
Eris Lifesciences designates Gopal Agrawal, Nita Borkar in leadership roles Ruchika Sharma2 April 2025 1:16 PM ISTMumbai: Eris Lifesciences Limited, an Indian branded formulations manufacturing company, has designated Gopal Agrawal and Nita Borkar in...
